Figure 4From: Ezetimibe/simvastatin 10/40 mg versus atorvastatin 40 mg in high cardiovascular risk patients with primary hypercholesterolemia: a randomized, double-blind, active-controlled, multicenter studyPercentage of subjects attaining prespecified LDL-C targets after 6 weeks of treatment (Full Analysis Set population).Back to article page